Teva Pharmaceuticals USA recalls Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-
Recalled May 30, 2018 · FDA recall D-0857-2018 · Teva Pharmaceuticals USA
Hazard
Failed Stability Specifications · FDA Class III
Units
30,382 patches
Sold at
United States
Description
Failed Stability Specifications
Product
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →